Loading...
Market
Where will the glaucoma treatment and retina implant trials expand by October 2025?
2
Resolution / Starting Odds
Europe • 25%
Asia • 25%
South America • 25%
No expansion • 25%
Announcements from research institutions and clinical trial registries
Story
Study Shows First-of-Its-Kind Glaucoma Treatment and Retina Implant Improves Reading Ability in 38 Blind Participants
Oct 29, 2024, 11:50 AM
Recent research has demonstrated promising advancements in vision restoration for individuals with severe vision loss. A study involving 38 participants who were legally blind showed that a tiny chip, functioning as a replacement retina, was successfully implanted. Preliminary results indicated a significant enhancement in the participants' ability to read an eye exam scale. This innovative approach marks a potential breakthrough in glaucoma treatment, with the first-of-its-kind therapy now being utilized in Massachusetts. Researchers noted that this is the first instance of restoring the ability to read fluently among blind patients, highlighting the significance of these findings in the field of ophthalmology.
View original story
Similar markets
0-5 patients • 25%
6-10 patients • 25%
11-15 patients • 25%
More than 15 patients • 25%
0-10 patients • 25%
11-20 patients • 25%
21-30 patients • 25%
More than 30 patients • 25%
0-25% • 25%
26-50% • 25%
51-75% • 25%
76-100% • 25%
Successful full-eye transplant with vision restoration • 25%
Partial vision restoration in transplanted eyes • 25%
No significant advancements • 25%
Other significant advancements • 25%
0 countries • 25%
1-2 countries • 25%
3-4 countries • 25%
5 or more countries • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
Japan • 25%
USA • 25%
EU • 25%
Other • 25%
Significant improvement • 25%
Moderate improvement • 25%
No significant improvement • 25%
Worsening of symptoms • 25%
Yes • 50%
No • 50%
Russia • 25%
Europe (excluding Russia) • 25%
North America • 25%
Asia (excluding Russia) • 25%